Quantcast

Latest Atrial septal defect Stories

2009-11-16 07:31:00

MORRISVILLE, N.C., Nov. 16 /PRNewswire/ -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for non-invasive treatment for heart conditions, today announced the initiation of a clinical trial designed to evaluate the safety and efficacy of its Numeris® - AF Tethered Coagulation System with VisiTrax® device in an open-chest concomitant procedure for the treatment of longstanding persistent atrial fibrillation (AF). This...

2009-09-23 10:20:00

JENA, Germany, September 23 /PRNewswire/ -- Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders. The district court of Frankfurt reversed its earlier decision that was based on a request by AGA Medical, relying...

2009-09-21 10:54:00

ZURICH, September 21 /PRNewswire/ -- Occlutech AG, the leading European developer of products for septal closure, today announced that, together with its partner in Spain IZASA SA, it defeated a request for an injunction against sales and marketing activities in Spain, launched at the Commercial Court I of Barcelona, Spain by its U.S. competitor AGA Medical. The request by AGA was based on alleged patent infringement and unfair competition claims related to wrongful assumptions and...

2009-05-12 04:21:00

JENA, Germany, May 12 /PRNewswire/ -- Occlutech, the leading European developer of septum occluders, today announced that it has obtained CE mark approval for its new generation ASD and PFO occluders, the Figulla Flex. The Figulla Flex ASD and PFO occluders encompass a new innovative delivery system, making the use of a threaded hub unnecessary. The implantation of the occluder is facilitated by the ability of the delivery system to allow a 45 degree angle before release. The...

2009-03-19 09:56:00

JENA, Germany, March 19 /PRNewswire/ -- Occlutech GmbH today announced that it had defeated a request for insolvency, launched at the Amtsgericht Gera in Germany by its US competitor AGA Medical. The request by AGA was based on wrongful assumptions about Occlutech, and AGA announced that it had started the said request to recover damages. However, the court - Amtsgericht Gera in Germany - stated, that a proceeding regarding any damages has not yet been started. "Occlutech...

2009-03-17 08:00:00

ARLINGTON, Va., March 17 /PRNewswire-USNewswire/ -- The following was released today by The HealthCentral Network: WHAT: MyMigraineConnection.com and Teri Robert, patient advocate and Migraine expert on MyMigraineConnection.com, have kicked off their popular annual "Putting Our Heads Together" Poetry Contest. The contest, in its ninth year, seeks the most creative and influential pieces of poetry on how Migraine disease and/or headache disorders affect each entrant's life. Everyone who...

2009-02-23 10:39:06

A simple procedure may be the key to relief for some who suffer from frequent and severe migraine headaches. In a new study, researchers found significant improvement of migraines following catheter-based closure of the patent foramen ovale (PFO) -- a slight opening in the wall between the heart's right and left atria. Each of us has a PFO in the womb to divert blood away from the lungs, but it closes for three out of four people after birth, researchers said. Previous studies have already...

2009-02-17 10:45:12

Reducing the frequency and severity of disabling migraines is crucial for quality of life. A new study, published in the February 2009 issue of JACC: Cardiovascular Interventions, finds significant improvement of migraine following catheter-based closure of patent foramen ovale (PFO)"”a slight opening in the wall between the right and left atria.These findings confirm those of previous observational studies, which consistently show that when a PFO is closed"”whether it's following...

2009-01-07 07:00:00

MINNEAPOLIS, Jan. 7 /PRNewswire/ -- AGA Medical Corporation ("AGA Medical") announced today that it received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its AMPLATZER(R) Duct Occluder (ADO). The ADO is a percutaneous, transcatheter occlusion device used for the non-surgical closure of patent ductus arteriosus (PDA), a common type of congenital heart defect that occurs when a blood vessel known as the ductus arteriosus fails to close after birth, as it...

2008-12-03 01:00:00

MINNEAPOLIS, Dec. 3 /PRNewswire/ -- AGA Medical Corporation announced today that it received European CE Mark (Conformite Europeenne) approval for its AMPLATZER(R) Cardiac Plug (ACP). The ACP provides an innovative, minimally invasive solution for closing cardiac structures not involving the septal wall. One such intended use will be for the non-surgical occlusion of the left atrial appendage. "The ACP is an important addition to the interventional tools we have for structural heart...


Latest Atrial septal defect Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related